In conclusion, this study demonstrated that the pretreatment PNI, tumor size, clinical nodal status, histological grade, and Ki67 expression could serve as independent predictive factors for pCR in breast cancer patients treated with NAC. The gene discussed is MKI67; the disease is breast carcinoma.